China Approves Eli Lilly’s Orforglipron Weight-Loss Drug
China approved Eli Lilly’s oral GLP-1 weight-loss drug orforglipron.
Related stories
India Plans to Bar Private Equity Control of Multiple Nonbank Lenders
Sources say India plans to prohibit private equity firms from controlling multiple nonbank credit institutions.
M impact | REGULATION | Nov 12, 2026, 07:59 AM UTC
India Plans to Bar Private Equity Firms From Controlling Lenders
India plans to bar private equity firms from controlling multiple non-bank lenders, according to informed sources.
M impact | REGULATION | Nov 12, 2026, 07:58 AM UTC
India Central Bank Proposes Limits on PE Control of Non-Bank Lenders
India's central bank is working on proposals to prevent private equity firms from holding controlling stakes in more than one non-bank lender, two people familiar with the plans sa
L impact | REGULATION | Nov 12, 2026, 07:58 AM UTC
India to ban PE firms from controlling multiple non-bank lenders
Sources say India will ban private equity firms from controlling multiple non-bank lenders.
M impact | REGULATION | Nov 12, 2026, 07:58 AM UTC
India Central Bank Plans Limits on PE Stakes in Non-Bank Lenders
India's central bank plans to bar private equity firms from controlling more than one non-bank lender, sources say.
L impact | REGULATION | Nov 12, 2026, 07:58 AM UTC
EU to Clear More Sanctions Against Russia on Monday, France’s Haddad Says
France’s Haddad says the EU is set to clear additional sanctions against Russia on Monday.
L impact | REGULATION | Nov 12, 2026, 07:35 AM UTC